Table 1.

Survival data for lsq4 recombinant-congenic lines in liquid medium.

Strain	N	Lost	Median life-span	P	90th-percentile	MLS
EXPERIMENT 1
CL2a	61	4	14.5 days	–	25.5 days	29.5 days
SR705	63	3	16.5 days	0.8	25.5 days	32.5 days
SR706	64	2	15.5 days	0.7	25.5 days	31.5 days
SR707	61	6	14.5 days	0.7	26.5 days	31.5 days
Mean ± SD			15.25 ± 1.0		25.75 ± 0.5	31.25 ± 1.3
SR701	61	5	11.5 days	<0.001	18.5 days	21.5 days
SR708	64	3	11.5 days	<0.001	18.5 days	23.5 days
SR709	54	5	12.5 days	<0.001	17.5 days	24.5 days
SR710	66	2	11.5 days	<0.001	18.5 days	22.5 days
SR711	58	4	11.5 days	<0.001	16.5 days	23.5 days
Mean ± SD			11.7 ± 0.4		17.9 ± 0.9	23.1 ± 1.1
EXPERIMENT 2
CL2a	62	3	16.5 days	–	24.5 days	30.5 days
SR705	60	3	16.5 days	0.8	26.5 days	30.5 days
SR706	55	1	15.5 days	0.7	25.5 days	30.5 days
SR707	66	2	15.5 days	0.7	25.5 days	32.5 days
Mean ± SD:			16.0 ± 0.6		25.5 ± 0.8	31.0 ± 1.0
SR701	66	2	13.5 days	<0.001	18.5 days	22.5 days
SR708	58	2	12.5 days	<0.001	17.5 days	22.5 days
SR709	70	7	12.5 days	<0.001	19.5 days	23.5 days
SR710	60	4	12.5 days	<0.001	18.5 days	23.5 days
SR711	69	6	13.5 days	<0.001	20.5 days	21.5 days
Mean ± SD:			12.9 ± 0.5		18.9 ± 1.1	22.7 ± 0.8

P values were determined in each comparison of CL2a to the congenic line SR701, or to any of the SR701-derived recombinants (SR705, SR706, SR707, SR708, SR709, SR710, or SR711) by the Cox–Mantel test (Lee and Wang, 2003). All terms are defined as in the Table 1 legend.